BioCentury | Jul 30, 2019
Financial News

June 30 Financial Quick Takes: $40M series B for Hinova; plus TriArm and PredictImmune raise rounds

...by Hermed Capital and Shanghai Fosun Pharmaceutical Group Co. Ltd. (Shanghai:600196; HKSE:2196), with participation from Lang Sheng Investment...
Items per page:
1 - 1 of 1
BioCentury | Jul 30, 2019
Financial News

June 30 Financial Quick Takes: $40M series B for Hinova; plus TriArm and PredictImmune raise rounds

...by Hermed Capital and Shanghai Fosun Pharmaceutical Group Co. Ltd. (Shanghai:600196; HKSE:2196), with participation from Lang Sheng Investment...
Items per page:
1 - 1 of 1